NC
AVNS

Northpointe Capital’s Avanos Medical AVNS Stock Holding History

Northpointe Capital’s Portfolio AVNS Stock Details AVNS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-30,893
Closed -$1.38M – 92
2018
Q4 		$1.38M Sell
30,893
-17,899
-37% -$938K 0.31% 130
2018
Q3 		$3.34M Sell
48,792
-13,045
-21% -$840K 0.48% 98
2018
Q2 		$3.54M Sell
61,837
-38,146
-38% -$2.02M 0.47% 91
2018
Q1 		$4.61M Sell
99,983
-11,837
-11% -$562K 0.58% 63
2017
Q4 		$5.16M Sell
111,820
-83,523
-43% -$3.84M 0.58% 59
2017
Q3 		$8.8M Sell
195,343
-13,083
-6% -$558K 0.94% 25
2017
Q2 		$8.19M Sell
208,426
-15,464
-7% -$584K 0.86% 33
2017
Q1 		$8.53M Sell
223,890
-45,558
-17% -$1.78M 0.93% 34
2016
Q4 		$9.96M Buy
+269,448
New +$9.63M 0.99% 35

Other funds holding AVNS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PIM
Paradice Investment Management Denver, Colorado $532M AUM 29.6% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Northpointe Capital's AVNS Position: Q1 2019 in Review

Northpointe Capital sold out of Avanos Medical (AVNS) in Q1 2019, closing a stake of 30,893 shares — an estimated $1.38M sold.

Northpointe Capital first reported a position in AVNS in Q4 2016 and held it in 9 quarters. The position peaked at $9.96M in Q4 2016. 338 funds tracked by Wall St. Rank hold AVNS as of Q1 2019.

  • Northpointe Capital reported no remaining Avanos Medical position as of Q1 2019 after selling out during the quarter.
  • Northpointe Capital sold 30,893 Avanos Medical shares in Q1 2019, an estimated $1.38M.
  • Northpointe Capital first reported a position in Avanos Medical in Q4 2016 and held it in 9 quarters.
  • Northpointe Capital's Avanos Medical position peaked at $9.96M in Q4 2016.
  • 338 funds tracked by Wall St. Rank held Avanos Medical as of Q1 2019.

Based on Northpointe Capital's 13F filing for Q1 2019, filed 17 Apr 2019.